BRUNA PURGATO DANTAS: Open Payments
NPI 1871915645 · OAKLAND PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,232 in 116 payments from 14 companies in 2025. Trend: 2023 $2,037 · 2024 $1,369 · 2025 $2,232
Food & beverage: $2,232
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 29 | $607 |
| Gilead Sciences, Inc. | 25 | $567 |
| Merck Sharp & Dohme LLC | 9 | $218 |
| ABBVIE INC. | 9 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $152 |
| Novo Nordisk Inc | 8 | $140 |
| EMD Serono, Inc. | 6 | $119 |
| Lundbeck LLC | 4 | $80 |
| Amgen Inc. | 3 | $51 |
| Napo Pharmaceuticals Inc | 2 | $38 |
Products named: DOVATO, CABENUVA, PIFELTRO, CAPLYTA, Yeztugo, RUKOBIA, REXULTI, HUMIRA.
Industry payments across FL — which companies pay providers there.
